701-1146

completed

Safety and Efficacy of the Xanomeline Transdermal Therapeutic System (TTS) in Patients with Mild to Moderate Alzheimers Disease. · Phase II
701 (USA) · Dr. Reyes
consented 2013-05-20

AEs

Serious

Dropout signal

–

Adverse events

mild assessed

Mild APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-10 (study day 22.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE ERYTHEMA — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-10 (study day 22.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE IRRITATION — outcome: RECOVERED/RESOLVED; onset 2013-06-01 (study day 13.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE IRRITATION — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-26 (study day 38.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE PAIN — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-22 (study day 34.0); relationship: PROBABLE

mild assessed

Mild APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-10 (study day 22.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE PRURITUS — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-10 (study day 22.0); relationship: PROBABLE

moderate assessed

Moderate APPLICATION SITE VESICLES — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-26 (study day 38.0); relationship: PROBABLE

mild assessed

Mild FATIGUE — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-06-03 (study day 15.0); relationship: POSSIBLE

mild assessed

Mild RASH — outcome: NOT RECOVERED/NOT RESOLVED; onset 2013-05-16 (study day -4.0); relationship: NONE

mild assessed

Mild RASH — outcome: RECOVERED/RESOLVED; onset 2013-05-16 (study day -4.0); relationship: NONE

Data queries

No data queries.